Enrollment Delays Kill Phase III Timelines. EHR Phenotyping Fixes That.
TrialVyx matches eligible patients to open trial slots using de-identified EHR phenotype signals — reducing the 18-month enrollment window to under 9 months without adding sites.
From Patient Records to Trial-Ready Referrals
TrialVyx ingests de-identified EHR phenotype signals from partner sites and uses protocol-aware AI to match patients against open trial inclusion/exclusion criteria — in real time. No PHI transmitted. No manual chart review.
- FHIR R4 compatible EHR data ingestion
- De-identified phenotype extraction — no PHI leaves the site
- Real-time match scoring against open trial protocols
- Pre-screened referral delivery to sites — 47% lower screen failure
Built for Both Sides of the Trial
Cut Enrollment Timelines
Phase II/III sponsors using TrialVyx get AI-matched, pre-screened referrals across their site network — accelerating enrollment and reducing per-patient recruitment cost.
- Reduce enrollment window from months to weeks
- AI site selection based on real patient population signals
- Real-time enrollment dashboard across all sites
- Lower cost per enrolled patient
Receive Pre-Screened Patients
Clinical research sites partnering with TrialVyx receive high-quality patient referrals matched to active trial criteria — reducing screen failure waste and coordinator burden.
- Pre-screened referrals — fewer wasted screen visits
- Reduced coordinator workload on eligibility review
- Visibility into your site's enrollment performance
- Access to more sponsored trial opportunities
Real-Time Enrollment Intelligence
Track site performance, monitor patient match scores, and act on enrollment signals — all from a single dashboard built for clinical operations teams.
Three Steps to Faster Enrollment
Connect EHR
FHIR-compatible data ingestion. De-identified phenotype extraction from partner EHR systems. No PHI transmitted.
AI Matching
Criteria mapping against open trial protocols. Real-time scoring of patient eligibility. Continuous protocol updates.
Enroll Faster
Sites receive pre-screened referrals. Sponsors see enrollment acceleration. Dashboard tracks progress in real time.
Enrollment Window Cut from 22 Months to 11 Months
A Phase III oncology sponsor deployed TrialVyx across 14 sites. AI phenotype matching reduced screen failure rate by 52% and hit enrollment targets in half the projected time.
Read Case Study"The EHR phenotyping approach caught eligible patients our traditional site activation process was completely missing. We enrolled 40% faster than our last comparable trial — and the site coordinators told us the referral quality was the highest they'd seen."
